Showing results (311-320 of 1,214) with videos related to

Sort By:
Pageof 122
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in womenR J Baber, C Templeman, T Morton, et al.
Case Reports in Urology|May 16, 2022
Robot-Assisted Nephroureterectomy for Upper Tract Urothelial Carcinoma in a Patient with an Ileal ConduitRaymond A Stemrich, Neel Hasmukh Patel, Jacob A Baber, et al.
Bioorganic & Medicinal Chemistry|October 9, 2007
The use of ligand-based de novo design for scaffold hopping and sidechain optimization: two case studiesMiklos Feher, Yinghong Gao, J Christian Baber, et al.
BMC Public Health|January 6, 2024
The use of technology to address loneliness and social isolation among older adults: the role of social care providersElisabeth Grey, Fran Baber, Estelle Corbett, et al.
JACC. Cardiovascular Interventions|October 22, 2016
Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsGennaro Giustino, Roxana Mehran, Roland Veltkamp, et al.
Anaesthesia and Intensive Care|January 30, 2014
A randomised controlled trial of parecoxib, celecoxib and paracetamol as adjuncts to patient-controlled epidural analgesia after caesarean deliveryM J Paech, N J McDonnell, A Sinha, et al.
Biopharmaceutics & Drug Disposition|January 1, 1981
Bioavailability of sustained release propranolol formulationsJ McAinsh, N S Baber, B F Holmes, et al.
Scandinavian Journal of Rheumatology|January 1, 1980
The effect of indomethacin on renal function in manN Baber, L Halliday, T Littler, et al.
The American Journal of Cardiology|November 7, 2009
Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial diseaseUsman Baber, Devin Mann, Daichi Shimbo, et al.
Expert Review of Cardiovascular Therapy|October 17, 2018
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney diseasePaul Guedeney, Sabato Sorrentino, Birgit Vogel, et al.
Pageof 122